12 Steven Cohen T2 Biosystems Trades
The first T2 Biosystems trade was made in Q2 2015. Since then Steven Cohen bought shares five more times and sold shares on six occasions. The investor sold all their shares in Q3 2019 and doesn't own any shares in T2 Biosystems anymore.
Avg closing price
Price range
Sold -120 shares
Q3 2019
Avg closing price
$8,026.50
Price range
$2,890.00
-
$15,050.00
Increased shares by 90.5% (+57 shares)
Q1 2019
Avg closing price
$17,014.75
Price range
$12,800.00
-
$22,400.00
Sold 4.5% shares (-3 shares)
Q4 2018
Avg closing price
$23,490.87
Price range
$14,900.00
-
$34,300.00
Increased shares by 123.3% (+37 shares)
Q2 2018
Avg closing price
$37,950.78
Price range
$29,850.00
-
$47,900.00
New holding (+30 shares)
Q3 2017
Avg closing price
$18,573.02
Price range
$12,600.00
-
$33,900.00
Sold -73 shares
Q1 2017
Avg closing price
$28,116.94
Price range
$25,350.00
-
$31,250.00
Sold 51.0% shares (-76 shares)
Q4 2016
Avg closing price
$30,810.32
Price range
$24,450.00
-
$36,350.00
Sold 26.1% shares (-53 shares)
Q3 2016
Avg closing price
$32,845.31
Price range
$24,800.00
-
$39,750.00
Sold 7.3% shares (-16 shares)
Q2 2016
Avg closing price
$45,142.97
Price range
$39,450.00
-
$54,600.00
Increased shares by 120.0% (+120 shares)
Q4 2015
Avg closing price
$53,946.88
Price range
$44,600.00
-
$60,600.00
Increased shares by 185.7% (+65 shares)
Q3 2015
Avg closing price
$66,446.88
Price range
$43,800.00
-
$84,400.00
New holding (+35 shares)
Q2 2015
Avg closing price
$86,752.38
Price range
$74,600.00
-
$97,450.00
News about T2 Biosystems Inc and Steven Cohen
T2 Biosystems Advances to the Phase 2 in HHS and the Steven and Alexandra Cohen Foundation’s LymeX Diagnostics Prize
LEXINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibio...
HHS and the Cohen Foundation Name T2 Biosystems a Phase 1 Winner in LymeX Diagnostics Prize
LEXINGTON, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibio...